BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories
BD (NYSE: BDX), a leading medical technology company, has achieved a significant milestone as its Urology and Critical Care (UCC) and Surgery business units became the first in the medical technology industry to receive the diamond-level rating across all seven supply chain resilience domains from the Healthcare Industry Resilience Collaborative (HIRC).
The achievement follows a rigorous audit process evaluating multiple areas including demand planning, supplier management, inventory management, logistics, supply chain visibility, risk management, and operational health. This recognition builds upon BD's previous Transparency Partner Badge received in 2023 and reflects the company's ongoing investments in supply chain and manufacturing operations improvements.
BD (NYSE: BDX), un'azienda leader nel settore della tecnologia medica, ha raggiunto un traguardo importante: le sue divisioni Urologia e Cure Critiche (UCC) e Chirurgia sono diventate le prime nell'industria della tecnologia medica a ottenere la valutazione di livello diamante in tutti e sette i domini della resilienza della catena di fornitura dal Healthcare Industry Resilience Collaborative (HIRC).
Questo risultato arriva dopo un rigoroso processo di audit che ha valutato diversi ambiti, tra cui pianificazione della domanda, gestione dei fornitori, gestione dell'inventario, logistica, visibilità della catena di fornitura, gestione del rischio e salute operativa. Questo riconoscimento si basa sul precedente Transparency Partner Badge ricevuto da BD nel 2023 e riflette gli investimenti continui dell'azienda nel miglioramento delle operazioni di supply chain e produzione.
BD (NYSE: BDX), una empresa lÃder en tecnologÃa médica, ha alcanzado un hito significativo: sus unidades de negocio de UrologÃa y Cuidados CrÃticos (UCC) y CirugÃa se convirtieron en las primeras en la industria de tecnologÃa médica en recibir la calificación de nivel diamante en los siete dominios de resiliencia de la cadena de suministro otorgada por el Healthcare Industry Resilience Collaborative (HIRC).
Este logro sigue a un riguroso proceso de auditorÃa que evaluó múltiples áreas, incluyendo planificación de la demanda, gestión de proveedores, gestión de inventarios, logÃstica, visibilidad de la cadena de suministro, gestión de riesgos y salud operativa. Este reconocimiento se basa en la insignia Transparency Partner Badge recibida por BD en 2023 y refleja las inversiones continuas de la compañÃa en mejoras de operaciones de cadena de suministro y manufactura.
BD (NYSE: BDX)ëŠ� ì„ ë„ì ì¸ ì˜ë£Œê¸°ìˆ 회사로서 비뇨기과 ë°� 중환ìž� 치료(UCC)와 ìˆ˜ìˆ ì‚¬ì—…ë¶€ê°€ ì˜ë£Œê¸°ìˆ ì‚°ì—…ì—서 처ìŒìœ¼ë¡œ Healthcare Industry Resilience Collaborative(HIRC)로부í„� 공급ë§� 회복ë � 7ê°� ì˜ì— 모ë‘ì—서 다ì´ì•„몬ë“� 등급ì� íšë“하는 중요í•� ì´ì •표를 달성했습니다.
ì� 성과ëŠ� 수요 계íš, 공급업체 ê´€ë¦�, ìž¬ê³ ê´€ë¦�, 물류, 공급ë§� 가시성, 위험 ê´€ë¦�, ìš´ì˜ ê±´ê°• ë“� 여러 분야ë¥� í‰ê°€í•˜ëŠ” 엄격í•� ê°ì‚¬ ê³¼ì •ì� ê±°ì³ ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�. ì� ì¸ì •ì€ 2023ë…„ì— BDê°€ ë°›ì€ Transparency Partner Badgeì—� 기반하며, 공급ë§� ë°� ì œì¡° ìš´ì˜ ê°œì„ ì—� 대í•� 회사ì� ì§€ì†ì ì� 투ìžë¥� ë°˜ì˜í•©ë‹ˆë‹�.
BD (NYSE : BDX), une entreprise de technologie médicale de premier plan, a atteint un jalon important : ses unités commerciales Urologie et Soins Critiques (UCC) ainsi que Chirurgie sont devenues les premières dans l'industrie des technologies médicales à recevoir la note niveau diamant dans les sept domaines de résilience de la chaîne d'approvisionnement du Healthcare Industry Resilience Collaborative (HIRC).
Cette réussite fait suite à un processus d'audit rigoureux évaluant plusieurs aspects, notamment la planification de la demande, la gestion des fournisseurs, la gestion des stocks, la logistique, la visibilité de la chaîne d'approvisionnement, la gestion des risques et la santé opérationnelle. Cette reconnaissance s'appuie sur le Transparency Partner Badge précédemment obtenu par BD en 2023 et reflète les investissements continus de l'entreprise dans l'amélioration des opérations de la chaîne d'approvisionnement et de la fabrication.
BD (NYSE: BDX), ein führendes Medizintechnikunternehmen, hat einen bedeutenden Meilenstein erreicht: Die Geschäftsbereiche Urologie und Intensivpflege (UCC) sowie Chirurgie sind die ersten in der Medizintechnikbranche, die von der Healthcare Industry Resilience Collaborative (HIRC) in allen sieben Bereichen der Lieferkettenresilienz die Diamantbewertung erhalten haben.
Diese Auszeichnung folgt auf einen strengen Auditprozess, der mehrere Bereiche bewertete, darunter Bedarfsplanung, Lieferantenmanagement, Bestandsverwaltung, Logistik, Transparenz der Lieferkette, Risikomanagement und operative Gesundheit. Diese Anerkennung baut auf dem Transparency Partner Badge auf, das BD 2023 erhalten hat, und spiegelt die fortlaufenden Investitionen des Unternehmens in die Verbesserung der Lieferketten- und Fertigungsprozesse wider.
- First medtech company to achieve diamond-level rating in all seven HIRC supply chain resilience domains
- Demonstrates enhanced supply chain transparency and operational efficiency
- Shows continued investment in supply chain and manufacturing operations improvements
- Implemented real-time order management insights for customers
- None.
"Achieving HIRC's Diamond Status Resiliency Badge recognizes BD's commitment to building a resilient end-to-end supply chain across multiple product categories and ourÌýrelentless pursuit ofÌýprocess excellence and continuous improvement," said Tony Ezell, executive vice president and president of the
HIRC is a non-profit health care supply chain trade association founded in 2019 by a group of health care systems and trading partners focused on increasing transparency and resiliency. The Resiliency Badge Program includes a rigorous auditÌýto assess supply chainÌýresiliency, ensuring alignment with Ìýstandards for supply continuity, risk mitigation and operational efficiency. After completing a comprehensive audit, HIRC recognized BD for differentiated resiliency in all domain areas for its Surgery and UCC businesses, including demand planning, supplier management, inventory management, logistics, supply chain visibility, risk management and continency planning, and operational health.
BD was one of the first companies recognized by HIRC after receiving the Transparency Partner Badge in 2023. This diamond-level distinction builds on that recognition and demonstrates BD's ongoing investment in its supply chain and manufacturing operations, including increasing safety stock and capacity to allow greater flexibility for the most critical products and improving order management interfaces so customers have real-time insights into supply and deliveries.
About BDÌý
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit Ìýor connect with us on LinkedIn at , X (formerly Twitter) Ìýor Instagram .Ìý
Contacts:Ìý | Investors:Ìý |
Fallon McLoughlin | Adam ReiffeÌý |
BD Corporate Communications | BD Investor RelationsÌý |
201.258.0361 | 201.847.6927Ìý Ìý |
Ìý
View original content to download multimedia:
SOURCE BD (Becton, Dickinson and Company)